Cristal Festival Europe

Deezer defines the power of music in engaging campaign to attract Gen Z

Retrieved on: 
Tuesday, August 23, 2022
D, Technology, Advertising, High fidelity, Perception, Ticker, TikTok, Cristal Festival Europe, Music, Buzzman L'il Buzzard, LinkedIn, Clio Awards, Instagram, Agency, News, Twitter, Industry, Life, Social media, Deezer, Facebook

PARIS, Aug. 23, 2022 /PRNewswire/ -- Deezer (DEEZR), is repositioning its brand to attract younger users. As a first step, a new marketing campaign launched on August 22 in France, Germany and Brazil. Award-winning French agency Buzzman was chosen as the main partner for the campaign, and the wider brand development.

Key Points: 
  • The global music streaming service launches a 360 marketing campaign in key markets, highlighting how music can elevate moods and perceptions.
  • With engaging visuals from photographer Lou Escobar, Deezer presents a number of intriguing scenarios that at first glance might not tell the full story.
  • "Working with Buzzman, we have created a disruptive, and engaging campaign, where music makes images come to life.
  • Additionally, Deezer is creating a TikTok challenge where people will enhance or change a situation with the power of music.

Deezer defines the power of music in engaging campaign to attract Gen Z

Retrieved on: 
Tuesday, August 23, 2022
D, Technology, Advertising, High fidelity, Perception, Ticker, TikTok, Cristal Festival Europe, Music, Buzzman L'il Buzzard, LinkedIn, Clio Awards, Instagram, Agency, News, Twitter, Industry, Life, Social media, Deezer, Facebook

PARIS, Aug. 23, 2022 /PRNewswire/ -- Deezer (DEEZR), is repositioning its brand to attract younger users. As a first step, a new marketing campaign launched on August 22 in France, Germany and Brazil. Award-winning French agency Buzzman was chosen as the main partner for the campaign, and the wider brand development.

Key Points: 
  • The global music streaming service launches a 360 marketing campaign in key markets, highlighting how music can elevate moods and perceptions.
  • With engaging visuals from photographer Lou Escobar, Deezer presents a number of intriguing scenarios that at first glance might not tell the full story.
  • "Working with Buzzman, we have created a disruptive, and engaging campaign, where music makes images come to life.
  • Additionally, Deezer is creating a TikTok challenge where people will enhance or change a situation with the power of music.

Fujifilm to Showcase Expanded Medical Imaging Portfolio at the RSNA 2021 Conference

Retrieved on: 
Tuesday, November 23, 2021
Exhibition, Heart, Lung, OEM, Radiology, CEO, Sale, Cristal Festival Europe, Magnetic resonance imaging, Technology, RSNA, FDR, Google Images, Diagnosis, Tomosynthesis, Cardiology, Solution, Laboratory, Fujifilm, Spine, History, OR, Persona, ICU, ER, Velocity, DBT, GLOBE, Endoscopy, Enterprise imaging, MRI, Artifact, Digital, Knowledge, FDA, CT, Mammography, Pharmaceutical industry, Medical imaging

Lexington, Mass., USA, Nov. 23, 2021 (GLOBE NEWSWIRE) -- FUJIFILM Healthcare Americas Corporation announced it will showcase its portfolio of medical imaging solutions at the 2021 Radiological Society of North America (RSNA) conference, booth #1911, held November 28 - December 2, 2021 at McCormick Place West in Chicago.

Key Points: 
  • Lexington, Mass., USA, Nov. 23, 2021 (GLOBE NEWSWIRE) -- FUJIFILM Healthcare Americas Corporation announced it will showcase its portfolio of medical imaging solutions at the 2021 Radiological Society of North America (RSNA) conference, booth #1911, held November 28 - December 2, 2021 at McCormick Place West in Chicago.
  • This is the companys first RSNA exhibition since integrating FUJIFILM Medical Systems U.S.A., Inc. and Hitachi Healthcare Americas on October 1, 2021.
  • Fujifilms medical imaging portfolio includes solutions for digital radiography, mammography, computed tomography, magnetic resonance imaging, ultrasound, endoscopy, and endosurgery.
  • The Synapse Enterprise Imaging portfolio provides healthcare professionals with the imaging and data access needed to deliver a complete patient record.

Fujifilm’s ASPIRE Cristalle Digital Mammography System Receives Health Canada Medical Device License

Retrieved on: 
Thursday, October 14, 2021
Hospital, Death, Technology, DBT, Radiology, Solution, Industry, DR, Canadian Cancer Society, Tomosynthesis, Cancer, Breast cancer, Compression, Health, Woman, Knowledge, Google Images, Cristal Festival Europe, Mammography, Survival, Patient, GLOBE, Health Canada, HCP, Partnership, Acquisition, Medical imaging, Medical device

Mississauga, Ont., Canada, Oct. 14, 2021 (GLOBE NEWSWIRE) -- FUJIFILM Canada Inc. announced today that the company has received Health Canada medical device license for its ASPIRE Cristalle digital mammography solution and its expansion of the partnership with Christie Innomed to offer the product with superior service in every province across the country.

Key Points: 
  • Mississauga, Ont., Canada, Oct. 14, 2021 (GLOBE NEWSWIRE) -- FUJIFILM Canada Inc. announced today that the company has received Health Canada medical device license for its ASPIRE Cristalle digital mammography solution and its expansion of the partnership with Christie Innomed to offer the product with superior service in every province across the country.
  • ASPIRE Cristalle is featured with Digital Breast Tomosynthesis (DBT) technology, also known as 3D mammography.
  • The ASPIRE Cristalle with DBT combines Fujifilms Hexagonal Close Pattern (HCP) capture technology and intelligent image processing to optimize dose and contrast based on individual breast composition.
  • Fujifilms ASPIRE Cristalle mammography system with DBT is available for purchase and shipping in Canada, beginning on October 1st, 2021.

Fujifilm’s ASPIRE Cristalle Digital Mammography System Receives Health Canada Medical Device License

Retrieved on: 
Thursday, October 14, 2021
Hospital, Death, Technology, DBT, Radiology, Solution, Industry, DR, Canadian Cancer Society, Tomosynthesis, Cancer, Breast cancer, Compression, Health, Woman, Knowledge, Google Images, Cristal Festival Europe, Mammography, Survival, Patient, GLOBE, Health Canada, CEO, HCP, Acquisition, Partnership, Medical imaging, Medical device

Mississauga, Ont., Canada, Oct. 14, 2021 (GLOBE NEWSWIRE) -- FUJIFILM Canada Inc. announced today that the company has received Health Canada medical device license for its ASPIRE Cristalle digital mammography solution, and announced its expansion of the partnership with Christie Innomed to offer the product with superior service in every province across the country.

Key Points: 
  • Mississauga, Ont., Canada, Oct. 14, 2021 (GLOBE NEWSWIRE) -- FUJIFILM Canada Inc. announced today that the company has received Health Canada medical device license for its ASPIRE Cristalle digital mammography solution, and announced its expansion of the partnership with Christie Innomed to offer the product with superior service in every province across the country.
  • ASPIRE Cristalle is featured with Digital Breast Tomosynthesis (DBT) technology, also known as 3D mammography.
  • The ASPIRE Cristalle with DBT combines Fujifilms Hexagonal Close Pattern (HCP) capture technology and intelligent image processing to optimize dose and contrast based on individual breast composition.
  • Fujifilms ASPIRE Cristalle mammography system with DBT is available for purchase and shipping in Canada, beginning on October 1st, 2021.